Agenus | AGEN - Loan Capital

Stock Price
3.01
Daily Change
-0.19 -5.94%
Monthly
2.38%
Yearly
28.09%
Q1 Forecast
3.23

Agenus reported $23.6M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Agenus USD 23.6M 448K Sep/2025
Amgen USD 50B 2.43B Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
CSL USD 10.42B 273M Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Gilead Sciences USD 22.14B 5M Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Glaxosmithkline GBP 20.02B 4.72B Sep/2025
Incyte USD 30.2M 5.17M Dec/2025
Intrexon USD 0 198.67M Jun/2024
J&J USD 39.44B 30M Dec/2025
Jiangsu Hengrui CNY 51.42M 5.94M Sep/2025
Karyopharm Therapeutics USD -0.93 0.67 Dec/2024
MacroGenics USD 70.26M 4K Sep/2025
Merck EUR 10.45B 4.15B Sep/2025
Merck USD 39.97B 6B Sep/2025
Northwest Biotherapeutics USD 11.04M 4.7M Sep/2023
Novartis USD 24.24B 174M Sep/2025
Novavax USD 223.63M 187K Sep/2024
Pfizer USD 57.41B 93M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Rigel Pharmaceuticals USD 0 0 Sep/2024
Sangamo BioSciences USD 0 0 Jun/2022
Veracyte USD 0 0 Mar/2025